首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1448780

全球失智症與阿茲海默症相關市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Dementia Associated with Alzheimer's Disease Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 122 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球阿茲海默症相關失智症的市場規模將從 2023 年的 76 億美元達到近 119.3 億美元，2024 年至 2032 年研究期間的CAGR為 5.14%。

與阿茲海默症相關的失智症屬於一種獨特形式的認知障礙，主要是由與阿茲海默症特徵一致的大腦變化引起的。阿茲海默症是失智症的主要原因，涵蓋了與這種認知障礙相關的絕大多數病例。

市場動態

與阿茲海默症相關的失智症周圍的情況受到幾個關鍵因素的影響。全球人口老化是主要促進因素，因為年齡是阿茲海默症的重要危險因子。人口結構的變化導致面臨風險的人數不斷增加，從而促進了研究工作的加強、診斷技術的進步和藥物的開發。正在進行的研究和臨床試驗旨在了解阿茲海默症的根本原因，識別生物標記並開發有效的治療方法。政府和非營利組織為研究、宣傳活動和支援服務提供資金。藥品市場受到發現可以改變疾病進程或控制其症狀的藥物的努力的影響。此外，對護理人員支援服務的需求正在上升，反映出受阿茲海默症影響的人數不斷增加。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球阿茲海默症相關癡呆市場的各個細分市場進行了包容性評估。與阿茲海默症行業相關的失智症的成長和趨勢為本研究提供了整體方法。

市場區隔

與阿茲海默症相關的失智症市場報告的這一部分提供了國家和區域層面的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按藥物類別

膽鹼能/膽鹼酯酶 (Che) 抑制劑
美金剛
聯合藥物（美金剛和多奈哌齊）
其他

按配銷通路

醫院藥房
零售
網上銷售

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的阿茲海默症相關失智症市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。與阿茲海默症相關的失智症市場的主要參與者包括 Merz Pharma、諾華公司、艾伯維公司、輝瑞公司、第一三共有限公司、小野製藥有限公司、強生服務公司、衛材有限公司(Eisai Co., Ltd.)、H. Lundbeck A/S、F. Hoffmann-La Roche Ltd. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：阿茲海默症相關失智症公司的競爭格局

失智症與阿茲海默症市場競爭有關
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Merz Pharma

公司簡介
公司收入
產品
最近的發展

Novartis AG

公司簡介
公司收入
產品
最近的發展

AbbVie Inc.

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Daiichi Sankyo Company Limited.

公司簡介
公司收入
產品
最近的發展

Ono Pharmaceutical Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Johnson & Johnson Services Inc.

公司簡介
公司收入
產品
最近的發展

Eisai Co. Ltd.

公司簡介
公司收入
產品
最近的發展

H. Lundbeck A/S

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113560

The global demand for Dementia Associated with Alzheimer's Disease Market is presumed to reach the market size of nearly USD 11.93 Billion by 2032 from USD 7.6 Billion in 2023 with a CAGR of 5.14% under the study period 2024 - 2032.

Dementia linked to Alzheimer's disease pertains to a distinct form of cognitive impairment primarily instigated by alterations in the brain consistent with the characteristics of Alzheimer's disease. Alzheimer's disease constitutes the predominant cause of dementia, encompassing a substantial majority of cases associated with this cognitive disorder.

MARKET DYNAMICS

The landscape surrounding dementia associated with Alzheimer's disease is influenced by several key factors. The increasing aging population globally is a primary driver, as age is a significant risk factor for Alzheimer's disease. The shift in demographics has resulted in a rising number of individuals at risk, prompting heightened research efforts, advancements in diagnostics, and developments in pharmaceuticals. Ongoing research and clinical trials seek to understand the underlying causes of Alzheimer's, identify biomarkers, and develop effective treatments. Government and nonprofit initiatives contribute to funding for research, awareness campaigns, and support services. The pharmaceutical market is influenced by efforts to discover drugs that can modify the course of the disease or manage its symptoms. Additionally, the demand for caregiver support services is rising, reflecting the increasing number of individuals affected by Alzheimer's disease.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dementia associated with alzheimer's disease. The growth and trends of dementia associated with alzheimer's disease industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dementia associated with alzheimer's disease market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Cholinergic/Cholinesterase (Che) Inhibitors
Memantine
Combined Drugs (Memantine & Donepezil)
Others

By Distribution Channel

Hospital Pharmacies
Retail
Online Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dementia Associated with Alzheimer's Disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dementia Associated with Alzheimer's Disease market include Merz Pharma, Novartis AG, AbbVie Inc., Pfizer, Inc., Daiichi Sankyo Company, Limited., Ono Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Eisai Co., Ltd., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE MARKET ANALYSIS BY DRUG CLASS

5.1 Overview by Drug Class
5.2 Historical and Forecast Data
5.3 Analysis by Drug Class
5.4 Cholinergic/Cholinesterase (ChE) Inhibitors Historic and Forecast Sales by Regions
5.5 Memantine Historic and Forecast Sales by Regions
5.6 Combined Drugs (Memantine & Donepezil) Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1 Overview by Distribution Channel
6.2 Historical and Forecast Data
6.3 Analysis by Distribution Channel
6.4 Hospital Pharmacies Historic and Forecast Sales by Regions
6.5 Retail Historic and Forecast Sales by Regions
6.6 Online Sales Historic and Forecast Sales by Regions

7 . GLOBAL DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE COMPANIES

8.1. Dementia Associated With Alzheimer'S Disease Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Merz Pharma
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Novartis AG
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. AbbVie Inc.
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Pfizer Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Daiichi Sankyo Company Limited.
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Ono Pharmaceutical Co. Ltd.
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Johnson & Johnson Services Inc.
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Eisai Co. Ltd.
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. H. Lundbeck A/S
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. F. Hoffmann-La Roche Ltd.
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Drug Class (USD MN)
Cholinergic/Cholinesterase (ChE) Inhibitors Market Sales by Geography (USD MN)
Memantine Market Sales by Geography (USD MN)
Combined Drugs (Memantine & Donepezil) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Market Sales by Geography (USD MN)
Online Sales Market Sales by Geography (USD MN)
Global Dementia Associated With Alzheimer'S Disease Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Dementia Associated With Alzheimer'S Disease Report
Market Research Process
Market Research Methodology
Global Dementia Associated With Alzheimer'S Disease Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Drug Class
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Drug Class (USD MN)
Cholinergic/Cholinesterase (ChE) Inhibitors Market Sales by Geography (USD MN)
Memantine Market Sales by Geography (USD MN)
Combined Drugs (Memantine & Donepezil) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Market Sales by Geography (USD MN)
Online Sales Market Sales by Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Companies Market Share Analysis